Journal article
Acute effects of oral pyridostigmine on memory and cognitive function in SDAT
Abstract
This study reports the effects of the anticholinesterase pyridostigmine on cognitive function in 15 elderly patients with senile dementia of the Alzheimer type (SDAT). Each patient was given placebo and pyridostigime 60 mg orally four times over 26 hours, with a seven day washout between, using a randomized double-blind cross-over design. There was no significant improvement in cognitive function following placebo or pyridostigmine. We did not …
Authors
Molloy DW; Cape RDT
Journal
Neurobiology of Aging, Vol. 10, No. 2, pp. 199–204
Publisher
Elsevier
Publication Date
March 1989
DOI
10.1016/0197-4580(89)90031-6
ISSN
0197-4580